Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.
about
The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy.Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas
P2860
Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.
@en
type
label
Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.
@en
prefLabel
Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.
@en
P2093
P2860
P1476
Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction
@en
P2093
Keishi Yamashita
Masahiko Watanabe
Natusya Katada
P2860
P2888
P304
P356
10.1007/S11748-015-0575-2
P50
P577
2015-08-01T00:00:00Z